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SResults: A total of 690 sections from 20 RAs were histologically examined. Arterial
media injury was signiﬁcantly less in the irrigated 50C group (depth; 3.1[2.5-3.5],
circ; 1.1[0.8-1.4], thinning; 32%) compared to the non-irrigated 65C (depth; 3.5[3.1-
4], circ; 1.9[1.5-2.4], thinning; 79%) and 90C groups (depth; 4[3.5-4], circ; 3.4[2.7-
3.8], thinning; 90%) (depth; P¼0.04, circ; P<0.001, thinning; P¼0.01). Denatured
collagen was rarely observed in the irrigated 50C group (7%) compared to the non-
irrigated 65C (47%) and 90C groups (91%) (P¼0.001). Nerve damage was similar
between the irrigated 50C group (2.5 [2.1 to 3.2]) and 65C group (2.8 [2.6 to 2.9])
(P¼1.00).Pre RSD 6 months FU p-value
BP systolic (mmHg) 152  9 133  4 0.02
BP diastolic
(mmHg)
80  5 74  6 0.04
Ejection fraction
(%)
69.2  9 69.6  9 0.68
MPRI* 1.73 1.82 0.70
Septum basal
(mm)
11.40 10.78 0.02
Septum mid (mm) 9.03 8.75 0.03
Septum apical
(mm)
5.87 5.27 0.03
*myocardial perfusion reserve indexConclusions: Irrigation during RF ablation signiﬁcantly reduces arterial and peri-
arterial tissue injury, while effectively injuring the autonomic nerves.
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Background: Catheter-based percutaneous renal denervation has shown durable
blood pressure reductions in adult patients with resistant hypertension. The objective
of this study was to evaluate long-term changes in renal artery nerve morphology
induced by bipolar radiofrequency (RF) energy.
Methods: The Vessix System (Boston Scientiﬁc, Natick, MA) was used for the renal
denervation procedures. The system consists of a RF generator and a low-pressure
balloon catheter with an exterior array of bipolar RF electrodes mounted in an offset
helical pattern. Juvenile Yorkshire swine (N¼17) were treated bilaterally. Renal artery
nerves affected by RF treatment were evaluated at 14, 28, and 180 days post-treatment
using histopathologic methods to assess quantity, size, and morphological changes.
Results: At 14 days, susceptible nerves (nerves within the RF treatment zone)
exhibited primarily degenerative changes (eg, vacuolization, hypercellularity,
inﬂammatory inﬁltrates, hemorrhage), while at 28 and 180 days, susceptible nerves
exhibited chronic changes (eg, intra/peri-fascicular ﬁbrosis, axonal loss, nerve/
fascicular atrophy). The average total number of nerves per plane of treated arterial
segment was signiﬁcantly increased at 180 days relative to 14 and 28 days, while the
average number of susceptible nerves per plane remained relatively constant over
time. The percentage of susceptible nerves was signiﬁcantly reduced at 180 days
relative to 14 and 28 days. The percentage of small nerves steadily increased over time
with a concomitant decrease in the number of large nerves.
Conclusions: Bipolar RF energy has an acute injurious effect (degeneration, necrosis)
on the renal artery nerves, which progresses to a chronic reactive phase by 28 days
post-renal denervation and which is evident for up to 6 months post-treatment.
Although the cause for the apparent increase in total nerves and decrease in average
nerve size over time is uncertain, these results could potentially reﬂect the plasticity of
nerve growth associated with increased age and size of the animals, or compensatory
efforts at target (ie, renal) re-innervation (eg, collateral sprouting).
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Background: Renal denervation (RDN) with the Symplicity Flex catheter signiﬁ-
cantly reduces blood pressure (BP) in patients with treatment-resistant hypertension. A
new, multielectrode catheter designed to deliver radiofrequency energy simulta-
neously to 4 treatment sites was designed to reduce treatment time and resource use
while providing a safe and effective denervation procedure. The Spyral multielec-
trode renal denervation system features a unipolar array of 4 electrodes mounted onB150 JACC Vol 62/18/Suppl B j Octoba nitinol shaft in a spiral conﬁguration and deliver radiofrequency energy (1 minute
per artery) in a controlled conﬁguration.
Methods: This prospective, non-randomized, open label, ﬁrst in man feasibility study
will enroll 50 patients. The primary safety endpoint is acute procedure safety asso-
ciated with the delivery and/or use of the Spyral catheter. The primary effectiveness
endpoint is change in ofﬁce BP from baseline to six months. Included subjects must
have resistant hypertension deﬁned as an ofﬁce systolic BP of 160 mm Hg ( 150
mmHg for type 2 diabetics) despite adherence to an antihypertensive regimen of at
least 3 drugs (preferably including a diuretic). Exclusion criteria include type 1 dia-
betes, renal artery stenosis >50% or renal artery aneurysm, prior renal artery inter-
vention, or an estimated glomerular ﬁltration rate of < 45mL/min/1.73m2. Subjects
will be followed at 1, 3 and 6 months and yearly to 3 years post RDN.
Results: Baseline characteristics for 29 enrolled subjects include age 64 years, 66%
male and 41% with diabetes. Baseline BP is 182  16/94  11 mm Hg and the mean
number of antihypertensive drugs is 4.7  1.3. The change in ofﬁce-based BP at 1
month is -1621/712 mm Hg (p<0.001 for systolic BP, p¼0.002 for diastolic BP).
The total RDN procedure time was 21.2 7.7 minutes. There were 2 femoral artery
pseudoaneurysms. No new renal artery stenosis or hypertensive emergencies occurred.
Conclusions: RDN using the Spyral multielectrode catheter can be safely delivered
with a procedure time less than half that of the Symplicity Flex catheter. Further
procedural details and 3 month follow-up will be presented.
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Renal sympathetic denervation: Does reduction of left ventricular mass translate
into improved intramyocardial perfusion?
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Background: Left ventricular (LV) hypertrophy is a common ﬁnding in patients with
resistant hypertension and is associated with an impaired intramyocardial perfusion.
Renal sympathetic denervation (RDN) has been shown to reduce blood pressure (BP)
and sympathetic tone. In this pilot study we aimed to investigate the effect of RDN on
LV wall thickness, myocardial function, and myocardial perfusion reserve at cardiac
magnetic resonance imaging (cMRI) in patients with resistant hypertension.
Methods: Resistant hypertension was deﬁned as mean systolic 24h BP > 145 mmHg
despite the use of at least 3 antihypertensive drugs. Adenosin-stress-induced cMRI
was performed at baseline, 3, and 6 months after RDN. RDN was performed bilat-
erally in the renal arteries using a single soft tip radiofrequency catheter (Symplicity,
Medtronic, U.S.).
Results: Six patients (5 males, 659 years) suffering from resistant hypertension,
despite the use of 51 antihypertensive drugs, were investigated. Resting systolic BP
signiﬁcantly decreased from 1529 mmHg to 1334 mmHg (p¼0.02), diastolic BP
from 804 mmHg to 746 mmHg (p¼0.04) at 6 months follow-up (FU). LV septal
wall thickness was signiﬁcantly reduced (basal 11.40 to 10.78 mm; p¼0.02, midseptal
9.03 to 8.75 mm; p¼0.03 and apical 5.87 to 5.28 mm; p¼0.03). No signiﬁcant
changes were found for LV ejection fraction and myocardial perfusion reserve index
at 6 months FU (Table).Conclusions: RDN signiﬁcantly reduced LV septal wall thickness as diagnosed by
cMRI, as well as systolic and diastolic BP. However, our pilot data do not show
a signiﬁcant change of the myocardial perfusion reserve. 6 months follow-up might
have been too short to lead to signiﬁcant changes in intramyocardial perfusion of
patients after RDN.er 27–November 1, 2013 j TCT Abstracts/POSTER/Renal Denervation
